Immunomedics, inc. (IMMU)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Sep'10
Cash flows from operating activities:
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest

-362,994

-357,319

-351,220

-321,106

-362,193

-310,347

-219,334

-273,887

-210,116

-233,878

-255,799

-153,266

-115,923

-70,624

-59,948

-59,136

-55,637

-53,404

-51,097

-48,123

-47,569

-45,315

-42,747

-35,531

-31,368

-13,253

-9,545

-11,486

-10,752

-26,631

-775

1,264

11,325

11,020

-13,073

-14,412

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Changes in fair value of warrant liabilities

-

-

-

-

-

47,596

21,014

108,610

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation and amortization

3,956

3,800

4,340

3,939

3,261

2,770

1,675

1,297

1,207

1,068

887

900

866

861

795

738

674

632

605

578

554

536

553

569

694

872

953

1,036

1,158

1,239

1,368

1,496

1,486

1,401

1,439

1,477

0

0

0

Loss on disposal of property and equipment

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on insurance claim for equipment failure

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

137

0

0

0

-

-

-

179

279

0

0

0

Amortization of discounts of auction rate securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

120

0

0

0

Interest on non-recourse debt

36,409

39,929

39,555

39,661

18,490

39,078

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on induced exchanges of debt

-

-

-

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of deferred revenue

-

-

-

-

-

81

154

77

97

129

65

64

73

58

40

36

2

-3

19

5

151

193

155

2,674

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of bond premiums

-

-

-

-

-

-39

-47

-30

-13

-52

-109

-218

-336

-448

-558

-670

-775

-691

-614

-544

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of debt issuance costs

45

50

181

204

318

252

145

1,678

1,735

1,970

2,116

730

730

730

729

730

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash lease expense

270

264

196

130

64

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of deferred rent

-

-

-

-

-

-350

-396

-278

-161

-43

23

-10

-192

-176

-149

-100

99

99

99

99

99

99

99

99

99

99

99

99

0

0

0

-

0

0

0

-

0

0

0

Loss on sale of marketable securities

-

-

-

-

-

-

-

-

-

-

-

-16

-15

-14

-14

2

2

2

5

11

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Decrease in allowance for doubtful accounts

-

-

-

-

-

-13

-12

-9

-17

-12

-48

-62

-63

-39

-8

20

17

-0

-14

-34

6

6

16

39

14

3

1

-5

6

16

39

22

0

0

0

-

-

-

-

Other

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Gain on sale of auction rate securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Non-cash expense related to stock-based compensation

13,841

11,736

6,479

5,033

3,981

3,568

5,174

4,024

4,412

4,230

4,142

4,333

3,493

3,220

3,618

3,741

3,511

3,239

3,124

2,788

2,932

3,192

3,360

3,218

2,932

2,604

2,220

2,265

2,225

2,214

2,078

2,059

0

0

0

-

-

-

-

Non-cash expense relating to issuance of stock options

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Non-cash decrease in value of life insurance policy

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

18

-49

-3

-3

-3

0

0

0

-

0

0

0

-

0

0

0

Changes in other operating assets and liabilities

0

-

0

0

0

-

-8,723

8,192

0

0

0

-

-

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

Net cash used in operating activities

-239,638

-222,442

-210,790

-197,837

-222,812

-200,311

-162,507

-133,425

-110,019

-94,520

-66,011

-62,250

-60,729

-58,146

-51,920

-48,462

-44,534

-41,245

-43,238

-38,996

-39,628

-35,140

-32,533

-30,690

-27,912

-9,680

-5,775

-5,899

-5,527

3,734

3,573

4,908

14,063

-13,449

-11,134

-12,186

0

0

0

Cash flows from investing activities
Purchases of marketable securities

-

-

-

-

-

135

10,134

10,379

0

0

0

-

-

-

-

2,749

0

0

0

-

-

-

-

44,116

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from sales/maturities of marketable securities

-

-

-

-

-

73,968

101,805

95,111

84,784

75,394

59,595

57,183

55,070

49,471

49,269

50,850

45,762

41,141

40,586

34,491

31,757

28,502

17,220

9,024

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Purchases of property and equipment

5,258

6,849

14,543

16,912

18,322

19,198

12,369

9,974

5,937

3,095

1,978

1,837

1,624

1,725

2,183

2,226

1,773

1,715

1,282

924

641

603

564

378

499

615

642

595

603

460

472

568

585

547

486

605

0

0

0

Proceeds from sales and redemptions of auction rate securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

9,545

0

0

0

Net cash used in investing activities

-5,258

-6,849

-14,543

4,906

28,765

54,635

79,300

74,756

-33,981

-40,395

-74,238

-76,264

24,285

18,585

46,337

45,875

37,231

-46,386

-49,003

-52,740

-74,802

1,065

-6,977

-35,069

-16,581

-20,742

-20,725

-457

-465

-322

-335

-568

-557

8,219

8,280

9,218

0

0

0

Cash flows from financing activities:
Proceeds from insurance claim for equipment failure

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

137

0

0

0

-

-

-

179

279

0

0

0

Exercise of stock options, net

760

2,553

2,326

2,282

3,264

1,772

1,780

2,261

3,475

4,849

4,796

4,290

4,387

2,680

2,695

2,733

0

0

0

-

-

-

-

1,799

1,868

1,281

1,117

266

217

217

225

171

246

253

243

243

0

0

0

Exercise of warrants

-

-

-

-

-

29,438

0

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from public offering of common stock

-

-

-

-

-

0

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from the issuance of non-recourse debt

-

-

-

-

-

182,216

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Debt conversion fees

-

-

-

-

-

3

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Tax withholding payments for stock-based compensation

-

-

-

-

-

1,664

1,639

1,523

1,620

403

491

546

500

377

390

369

384

549

582

585

563

336

258

331

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Payments for stock plan activity

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

-

-

-

-

Net cash provided by financing activities

345,388

347,181

9,443

9,607

326,726

579,010

622,191

627,900

428,833

190,877

174,852

168,804

47,165

30,880

2,305

2,364

2,228

98,829

98,862

98,716

126,229

30,277

30,439

31,277

1,534

15,775

15,595

14,765

14,741

1,538

1,598

1,655

1,656

107

120

147

0

0

0

Effect of changes in exchange rates on cash, cash equivalents and restricted cash

-32

-22

-50

-36

-177

-121

-37

-43

15

-11

-107

-100

-32

-24

-41

-26

220

-330

-280

-489

-725

-163

-125

118

152

58

27

79

-1

115

32

-255

0

0

0

-

-

-

-

Net decrease in cash, cash equivalents and restricted cash

100,460

117,868

-215,940

-183,360

132,502

433,213

538,947

569,188

284,847

55,948

34,495

30,190

10,689

-8,704

-3,320

-249

-4,853

10,867

6,339

6,491

11,073

-3,961

-9,197

-34,364

-42,808

-14,589

-10,877

8,487

8,747

5,065

4,869

5,740

15,348

-4,995

-2,528

-2,435

0

0

0

Supplemental disclosure of cash flow information:
Interest paid

338

338

338

644

644

950

950

2,850

2,850

4,750

4,750

4,750

4,750

4,750

4,750

4,803

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Schedule for non-cash investing and financing activities:
Issuance of common shares for debt conversion

-

-

-

-

-

151,736

137,979

217,979

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued capital expenditures

-2,907

101

-1,654

1,199

4,669

2,968

5,676

3,227

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash component of warrant exercise

-

-

-

-

-

-44,820

-9,466

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Shares received in cashless exercise

0

1,271

3,087

3,722

3,721

2,450

0

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Issuance of common stock due to debt conversion

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash lease expense

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in operating lease liabilities

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Market Offering
Proceeds from private offering of common stock

-

-

-

-

-

-50,475

419

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-